ILLUMINA, INC. (ILMN)
Data as of , from SEC Form 4 filings.
See up to 3 months of ILMN. The 7-day demo opens the 1M and 3M ranges and puts ILMN on your watchlist.
Start 7-day demoLatest ILMN insider trades
About ILLUMINA, INC. (ILMN)
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
- SAN DIEGO, CA
- 8,650
- 2000
- XNAS
ILMN Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 69 | 2,061,850 | $436.48M |
| Grant or award | 9 | 44,608 | |
| Tax withholding / forfeiture | 2 | 1,711 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
ILMN insider transactions (Form 4)
7899 Form 4 filings on record, the earliest from Oct 1, 2024, newest first. Filing history page 2 of 3.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Other | Common Stock | 255,378 | $102.82 | $26.26M | ||
| Other | Common Stock | 255,378 | $144.66 | $36.94M | ||
| Open-market sale | Common Stock | 159,623 | $145.26 footnote F5 | $23.19M | ||
| Open-market sale | Common Stock | 53,610 | $145.94 footnote F6 | $7.82M | ||
| Open-market sale | Common Stock | 6,524 | $147.50 footnote F7 | $962K | ||
| Open-market sale | Common Stock | 5,310 | $148.14 footnote F8 | $787K | ||
| Open-market sale | Common Stock | 12,309 | $144.13 footnote F9 | $1.77M | ||
| Open-market sale | Common Stock | 52,776 | $144.80 footnote F10 | $7.64M | ||
| Open-market sale | Common Stock | 25,352 | $146.15 footnote F11 | $3.71M | ||
| Open-market sale | Common Stock | 13,776 | $146.96 footnote F12 | $2.02M | ||
| Open-market sale | Common Stock | 180 | $147.80 footnote F13 | $27K | ||
| Other | Equity Swap (right to buy) | 255,378 | - footnote F3 | - | ||
| ||||||
| Other | Common Stock | 9,236 | $102.82 | $950K | ||
| Other | Common Stock | 9,236 | $140.25 | $1.30M | ||
| Other | Common Stock | 79,568 | $102.82 | $8.18M | ||
| Other | Common Stock | 79,568 | $143.45 | $11.41M | ||
| Other | Equity Swap (right to buy) | 9,236 | - footnote F3 | - | ||
| Other | Equity Swap (right to buy) | 79,568 | - footnote F4 | - | ||
| ||||||
| Christensen Jakob Wedel - Officer | Tax withholding / forfeiture | Common Stock | 233 | $139.07 | $32K | |
| Christensen Jakob Wedel - Officer | Open-market sale | Common Stock | 700 | $139.04 | $97K | |
| Grant or award | Common Stock | 190 footnote F1 | $131.55 | $25K | ||
| ||||||
| Grant or award | Common Stock | 161 footnote F1 | $131.55 | $21K | ||
| ||||||
| Grant or award | Performance Shares | 8,871 | $128.24 | $1.14M | ||
| Grant or award | Performance Shares | 8,871 | $128.74 | $1.14M | ||
| Grant or award | Common Stock | 7,603 footnote F1 | $128.24 | $975K | ||
| ||||||
| Scott M. Davies - Officer | Grant or award | Performance Shares | 6,824 | $128.24 | $875K | |
| Scott M. Davies - Officer | Grant or award | Common Stock | 5,849 footnote F1 | $128.24 | $750K | |
| Scott M. Davies - Officer | Grant or award | Performance Shares | 6,824 | $128.24 | $875K | |
| ||||||
| Ankur Dhingra - Officer | Grant or award | Performance Shares | 10,918 | $128.24 | $1.40M | |
| Ankur Dhingra - Officer | Grant or award | Performance Shares | 10,918 | $128.24 | $1.40M | |
| Ankur Dhingra - Officer | Grant or award | Common Stock | 9,358 footnote F1 | $128.24 | $1.20M | |
| ||||||
| Scott D. Ericksen - Officer | Grant or award | Performance Shares | 1,609 | $128.24 | $206K | |
| Scott D. Ericksen - Officer | Grant or award | Performance Shares | 1,609 | $128.24 | $206K | |
| Scott D. Ericksen - Officer | Grant or award | Common Stock | 3,217 footnote F1 | $128.24 | $413K | |
| ||||||
| Patricia Leckman - Officer | Grant or award | Performance Shares | 7,369 | $128.24 | $945K | |
| Patricia Leckman - Officer | Grant or award | Performance Shares | 7,369 | $128.24 | $945K | |
| Patricia Leckman - Officer | Grant or award | Common Stock | 6,317 footnote F1 | $128.24 | $810K | |
| ||||||
| Kevin Carl Pegels - Officer | Grant or award | Performance Shares | 7,369 | $128.24 | $945K | |
| Kevin Carl Pegels - Officer | Grant or award | Performance Shares | 7,369 | $128.24 | $945K | |
| Kevin Carl Pegels - Officer | Grant or award | Common Stock | 6,317 footnote F1 | $128.24 | $810K | |
| ||||||
| Jacob Thaysen - Officer | Grant or award | Common Stock | 25,734 footnote F1 | $128.24 | $3.30M | |
| Jacob Thaysen - Officer | Grant or award | Performance Shares | 30,022 | $128.24 | $3.85M | |
| Jacob Thaysen - Officer | Grant or award | Performance Shares | 30,022 | $128.24 | $3.85M | |
| ||||||
| Christensen Jakob Wedel - Officer | Grant or award | Performance Shares | 6,551 | $128.24 | $840K | |
| Christensen Jakob Wedel - Officer | Grant or award | Common Stock | 5,615 footnote F1 | $128.24 | $720K | |
| Christensen Jakob Wedel - Officer | Grant or award | Performance Shares | 6,551 | $128.24 | $840K | |
| ||||||
| Scott M. Davies - Officer | Open-market sale | Common Stock | 1,336 | $116.18 | $155K | |
| Tax withholding / forfeiture | Common Stock | 1,259 | $116.51 | $147K | ||
| Scott D. Ericksen - Officer | Tax withholding / forfeiture | Common Stock | 694 | $116.51 | $81K | |
| Kevin Carl Pegels - Officer | Tax withholding / forfeiture | Common Stock | 1,164 | $116.51 | $136K | |
| Scott M. Davies - Officer | Tax withholding / forfeiture | Common Stock | 1,037 | $116.51 | $121K | |
| Jacob Thaysen - Officer | Tax withholding / forfeiture | Common Stock | 6,544 | $116.51 | $762K | |
| Christensen Jakob Wedel - Officer | Tax withholding / forfeiture | Common Stock | 578 | $116.51 | $67K | |
| Patricia Leckman - Officer | Tax withholding / forfeiture | Common Stock | 1,304 | $116.51 | $152K | |
| Patricia Leckman - Officer | Open-market sale | Common Stock | 2,370 | $116.18 | $275K | |
| Tax withholding / forfeiture | Common Stock | 1,014 | $114.44 | $116K | ||
| Option exercise | Common Stock | 1,256 footnote F1 | $0.00 | - | ||
| Option exercise | Common Stock | 1,421 footnote F2 | $0.00 | - | ||
| Option exercise | Performance Shares | 1,256 footnote F1 | $0.00 | - | ||
| Option exercise | Performance Shares | 1,421 footnote F2 | $0.00 | - | ||
| ||||||
| Jacob Thaysen - Officer | Tax withholding / forfeiture | Common Stock | 5,470 | $114.44 | $626K | |
| Jacob Thaysen - Officer | Option exercise | Common Stock | 13,264 footnote F1 | $0.00 | - | |
| Jacob Thaysen - Officer | Option exercise | Performance Shares | 13,264 footnote F1 | $0.00 | - | |
| ||||||
| Kevin Carl Pegels - Officer | Tax withholding / forfeiture | Common Stock | 874 | $114.44 | $100K | |
| Kevin Carl Pegels - Officer | Option exercise | Common Stock | 2,283 footnote F1 | $0.00 | - | |
| Kevin Carl Pegels - Officer | Option exercise | Performance Shares | 2,283 footnote F1 | $0.00 | - | |
| ||||||
| Scott M. Davies - Officer | Tax withholding / forfeiture | Common Stock | 550 | $114.44 | $63K | |
| Scott M. Davies - Officer | Option exercise | Common Stock | 1,370 footnote F1 | $0.00 | - | |
| Scott M. Davies - Officer | Option exercise | Performance Shares | 1,370 footnote F1 | $0.00 | - | |
| ||||||
| Patricia Leckman - Officer | Tax withholding / forfeiture | Common Stock | 424 | $114.44 | $49K | |
| Patricia Leckman - Officer | Option exercise | Common Stock | 1,028 footnote F1 | $0.00 | - | |
| Patricia Leckman - Officer | Option exercise | Performance Shares | 1,028 footnote F1 | $0.00 | - | |
| ||||||
| Scott D. Ericksen - Officer | Tax withholding / forfeiture | Common Stock | 306 | $114.44 | $35K | |
| Scott D. Ericksen - Officer | Option exercise | Common Stock | 743 footnote F1 | $0.00 | - | |
| Scott D. Ericksen - Officer | Option exercise | Performance Shares | 743 footnote F1 | $0.00 | - | |
| ||||||
| Open-market purchase | Common Stock | 200 | $117.81 | $24K | ||
| Grant or award | Common Stock | 212 | $117.63 | $25K | ||
| Scott M. Davies - Officer | Open-market sale | Common Stock | 323 | $136.09 | $44K | |
Recent ILMN Form 144 notices of proposed sale
3An insider files Form 144 before selling restricted or control stock. It announces a planned sale. If the sale goes ahead, it shows up later on a Form 4.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| Corvex Management LP | Affiliate of Director (1) | 150,000 | $31.99M | View on EDGAR | |
| Corvex Management LP | Affiliate of Director (1) | 200,000 |
Stock trades in ILMN disclosed by members of the U.S. House in the last 12 months, newest first. Values are the ranges as filed.
| Member | Type | Traded | Disclosed | Value range | Owner | Days to disclose | Filing |
|---|---|---|---|---|---|---|---|
| Purchase |
ILMN insider trading FAQ
What is the latest insider trade for ILMN?
ILLUMINA, INC. (ILMN) had 12 insider filings in the last 90 days, with the most recent on 2026-10-07. The full record for ILMN runs to 99 Form 4 filings, the earliest from 2024-10-01. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying ILMN stock?
No insider purchases of ILMN were filed in the last 90 days. 10 purchases are on record for this company.
How many insiders are selling ILMN stock?
69 insider sales of ILMN were filed in the last 90 days, totaling $436.48M.
Where can I see ILMN SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects ILMN Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Jacob Thaysen view on EDGAR
- - Keith A. Meister view on EDGAR
- - Scott B. Ullem view on EDGAR
- - Julie Ann Coletti view on EDGAR
- - Steven Barnard view on EDGAR
- - Keith A. Meister view on EDGAR
- - Keith A. Meister view on EDGAR
- - Keith A. Meister view on EDGAR
- - Christensen Jakob Wedel view on EDGAR
Related companies with recent insider activity
Learn more
- Insider selling: signal or noise?
- Why most insider sales are routine, and the few patterns worth a second look.
- Form 144 vs Form 4
- A Form 144 announces a planned sale; the Form 4 reports it after it happens.
- Insider activity in Health Care
- Where ILMN's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow ILMN with a 7-day demo
- ILMN on your watchlist
- Every ILMN Form 4 filing on record
- Up to 3 months of ILMN price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive